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Oliguria on the Day of Intubation Is Associated
With Mortality in Patients With Acute Respiratory
Distress Syndrome
OBJECTIVES: To investigate the relationship between oliguric acute kidney injury
(AKI) and mortality in patients with acute respiratory distress syndrome (ARDS).
DESIGN: Retrospective cohort study.

Raef A. Fadel, DO1
Ivanna Murskyj, MD1
Elian Abou Asala, MD1
Nour Nasiri, MD1

SETTING: This investigation took place at a single-center, tertiary referral multidisciplinary comprehensive healthcare hospital in metropolitan Detroit, Michigan.

Ayman Alsaadi, MD1

PATIENTS: Adult patients 18 years old or older hospitalized in the ICU and diagnosed with ARDS on mechanical ventilation.

Daniel Ouellette, MD3

Ashley Scott, MD2

INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Three hundred eight patients were
included in the final analysis. Risk factors associated with mortality included advanced age (p < 0.001), increased body mass index (p = 0.008), and a history of
chronic kidney disease (p = 0.023). Presence of AKI by day 1 of intubation, with
elevated creatinine (p = 0.003) and oliguria (p < 0.001), was significantly associated with mortality. On multivariate analysis, advanced age (relative risk [RR], 1.02),
urine output on the day of intubation (RR, 0.388), bicarbonate level (RR, 0.948),
and Sequential Organ Failure Assessment severity score (RR, 1.09) were independently associated with mortality. A receiver operating characteristic curve identified a threshold urine output on the day of intubation of 0.7 mL/kg/hr (area under
the curve, 0.75; p < 0.001) as most closely associated with inpatient mortality (i.e.,
urine output < 0.7 mL/kg/hr is associated with mortality).
CONCLUSIONS: For patients with ARDS, oliguria on the day of intubation was
independently associated with increased mortality. Urine output of less than
0.7 mL/kg/hr predicted 80% of inpatient deaths. These findings herald an augmented understanding of the role of urine output in medical decision-making and
prognostication.
KEY WORDS: acute kidney injury; artificial ventilation; intensive care units; renal
failure; respiratory distress syndrome; urine

C

ritically ill patients often experience complex end-organ dysfunction
that contributes to a high mortality rate (1, 2). Acute kidney injury
(AKI) is a frequent complication due to a variety of insults that impact
renal function, including decreased renal perfusion in a shock state, medication
insults (e.g., nephrotoxic antimicrobials and vasoactive agents), and possibly
contrast (3). Such impact is further magnified in the presence of underlying
chronic kidney disease (CKD) (4). Many studies have demonstrated an association between AKI and poor outcomes in patients with acute respiratory distress
syndrome (ARDS) (3, 5), compounded by comorbid conditions (6).
In patients who develop AKI in the context of ARDS, it remains unclear
whether it is the metabolic effects of renal disease or the respiratory failure itself
that increases the mortality in this population. One investigation of patients
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previously enrolled in the ARDS Network (ARDSNet)
trial identified a correlation between low urine output
and increased mortality in hospitalized patients with
ARDS (7). Additionally, factors such as age, high clinical severity scores, and acidosis were associated with
the development of AKI in a cohort of patients with
ARDS (8).
The aim of this study was to investigate the relationship between oliguric AKI and mortality in patients
with ARDS. We hypothesized that oliguric AKI is an
independent risk factor for all-cause mortality in this
population.

MATERIALS AND METHODS
Study Design and Population
We performed a retrospective review of patients admitted to a single-center healthcare system in metropolitan Detroit, Michigan (Henry Ford Health System),
between December 2012 and February 2018.
Hospital charts were screened for patients 18 years
old or older, admitted to the ICU, and carrying a diagnosis of ARDS or acute respiratory distress. Patients
were included if they met the Berlin criteria for moderate or severe ARDS, with a Pao2/Fio2 ratio (P/F) of
less than 200 (9).
Patients were excluded if externally transferred to
or from Henry Ford Health System, if they did not
have consistent measurements of intake or output in
the electronic health record (EHR), if ventilator mechanics were not documented by respiratory therapy,
or if they required dialysis prior to onset of ARDS.
The study and waiver of informed consent
were approved by the Henry Ford Health System
Institutional Review Board (Number 14963).
Data Collection, Study Definitions, and
Calculations
All data were gathered through chart review and
manual abstraction of the EHR, selected based on the
above inclusion criteria. Baseline demographics, underlying comorbidities, clinical severity scores, and
outcomes were evaluated by the research team and
adjudicated by the study investigators. Body mass
index (BMI) was auto-calculated and abstracted from
the EHR. Mechanical ventilation data were obtained
from respiratory therapy flowsheets in the EHR for the
2     www.ccejournal.org

first 7 days of mechanical ventilation; days were defined by intubation day, with day 1 representing the
first day of intubation. Intake and output (I/O) data
were ascertained from nursing documentation, with
data screening per exclusion criteria above.
ARDS was defined by the 2012 Berlin definition (9).
Sequential Organ Failure Assessment (SOFA) scores
were calculated for the entire population.
AKI was defined by the Kidney Disease Improving
Global Outcomes 2012 guidelines, primarily based on
a reduction in urine output, calculated, and recorded
as milliliters of urine per body weight in kilograms
per hour (mL/kg/hr) (10). In our study, urine output
was determined on the day of intubation. All but seven
patients in the study also met criteria for AKI by creatinine level elevation, but this qualification was not
formally used.
Static compliance was calculated from abstracted
tidal volume, positive end-expiratory pressure (PEEP),
and plateau pressures according to the formula: static
compliance = tidal volume/(plateau pressure–PEEP).
Driving pressure was calculated from abstracted plateau pressures and PEEP according to the formula:
driving pressure = plateau pressure–PEEP. Vasopressor
and paralytic use were defined as any use during the
first 7 days of mechanical ventilation, not including induction for intubation.
Ventilator-free days (VFDs) was defined as the
number of days alive and free of mechanical ventilation
within 28 days after the initial intubation of the hospital stay of interest. Total ventilator days was defined
as total days on mechanical ventilation since primary
intubation. New renal replacement therapy (RRT) was
defined by the need for emergent RRT in the ICU with
no prior history of dialysis need. ICU and total length
of stay were defined as time to discharge (alive or deceased) during the index hospitalization.
Outcomes
The primary outcome was inpatient mortality.
Secondary outcomes included VFD, ICU length of
stay, and total hospital length of stay.
Statistical Analysis
Considering the primary dichotomous endpoint of
inpatient mortality, we predicted a baseline all-cause
mortality of 30% in patients with ARDS without AKI
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and 50% in patients with ARDS and AKI (8). With this,
we projected 182 total patients included in the analysis
would achieve 80% power, assuming a two-sided α less
than 0.05 to be statistically significant and reported
odds ratio with 95% CIs.
Continuous variables were described as medians
(with interquartile ranges) and categorical variables as
frequency rates and percentages. The Mann-Whitney
U test or t test were used for continuous variables,
whereas chi-square or Fisher exact tests were used for
categorical variables. A univariate analysis was performed to determine the association of underlying risk
factors with inpatient mortality.
Multiple logistic regression was performed with
in-hospital mortality as the dependent variable. Risk
factors were chosen for the model if they were significantly associated with the dependent variable by univariate analysis and if data were available for the risk
factor in at least 80% of the subjects. Of the risk factors significantly associated with in-hospital mortality
in the univariate analysis (Table 1; and Supplemental
Digital Content 1, http://links.lww.com/CCX/B11),
creatinine on day 1 of intubation was excluded from
the multivariate analysis due to collinearity with urine
output and less significant association. The remaining
risk factors were included in a multivariate model.
Complete data were available for a total of 306 of 308
subjects who were included in the analysis. For the
multivariate analysis, risk factors were considered to
be significantly associated with in-hospital mortality
for p values of less than 0.05. The odds ratio and CI
were reported for each risk factor.
A receiver operating characteristic (ROC) curve was
then used to model the performance of urine output

in predicting inpatient mortality, with determination
of a threshold value for application in clinical practice
with calculation of area under the curve (AUC) reported with 95% CIs, assuming a significance level of
0.05. Statistical analyses were performed using SPSS 27
(IBM, Armonk, NY).

RESULTS
A total of 1,195 patients were initially screened for enrollment. Four hundred sixty-four patients (40%) met
inclusion criteria based on age and presence of ARDS.
Of this group, 166 patients were excluded, with 298
patients included in the final analysis (Fig. 1).
Of the included patients, the majority were hospitalized for bacterial pneumonia (176 patients, 57%).
Approximately 169 (57%) were male, 161 (54%)
Caucasian, and 109 (37%) Black. Baseline demographics associated with mortality included advanced
age (52 ± 17 yr in alive vs 60 ± 17 in deceased; p < 0.001),
increased BMI (30 ± 9 vs 32 ± 11 kg/m2; p = 0.008),
and a history of CKD (33 vs 42 patients; p = 0.023).
Additionally, higher SOFA scores at admission to the
ICU were associated with increased mortality (10 ± 3
vs 12 ± 4; p < 0.001). Presence of AKI by day 1 of intubation was significantly associated with mortality,
as highlighted by elevated creatinine (1.56 ± 1.40 vs
1.93 ± 1.51 mg/dL; p = 0.003) and decreased urine
output (1.05 ± 0.87 vs 0.48 ± 0.52 mL/kg/hr; p < 0.001).
Additionally, bicarbonate levels were significantly
lower in deceased patients as compared with alive
(20.51 ± 5.16 vs 22.5 ± 5.71 mEq/L; p = 0.001).
Paco2, net I/O, and P/F on day 1 of intubation did
not statistically significantly differ between alive and

TABLE 1.

Multivariate Analysis of Risk Factors Associated With Dependent Variable of Inpatient Mortality
Risk Factors

p

Relative Risk (95% CI)

Age

1.020 (1.03–1.04)

0.019

Body mass index

1.021 (0.992–1.05)

0.161

Chronic kidney disease

1.114 (0.612–2.03)

0.724

Urine output on day 1 of MV

0.388 (0.230–0.654)

< 0.001

Bicarbonate on day 1 of MV

0.948 (0.901–0.997)

0.039

Sequential Organ Failure Assessment on admit to ICU

1.089 (1.01–1.18)

0.035

MV = mechanical ventilation.
Significant p < 0.05 are bolded.
Critical Care Explorations
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Figure 1. Receiver operating characteristic (ROC) curve of urine
output (in mL/kg/hr) as a risk factor for inpatient mortality.

deceased cohorts. Supplemental Digital Content 1
(http://links.lww.com/CCX/B11) highlights these
findings, including baseline demographics and risk
factors. Supplemental Digital Content 1 (http://links.
lww.com/CCX/B11) highlights the etiologies of ARDS
in included patients.
On multivariate analysis to assess risk factors independently associated with mortality, advanced age
(relative risk [RR], 1.02; 95% CI, 1.03–1.04; p = 0.019),
urine output on day 1 of intubation (RR, 0.388; 95%
CI, 0.230–0.654; p < 0.001), bicarbonate level on day
1 of intubation (RR, 0.948; 95% CI, 0.901–0.997; p =
0.039), and SOFA scores at admission to ICU (RR,
1.089; 95% CI, 1.01–1.18; p = 0.035) were independently associated with mortality (i.e., advanced age
and higher SOFA score are associated with increased
mortality, and elevated urine output and bicarbonate
appear to be protective). Table 1 demonstrates results
of the multivariate analysis.
Of the 464 patients meeting inclusion criteria, 10
patients had end-stage renal disease and required dialysis prior to the illness that led to the development
of ARDS. Of these 10 patients, three survived and
seven died. Six of the 10 renal failure patients had
non-negligible urine output on the day of intubation. The three survivors had urine outputs of 0.185,
0.506, and 1.187 mL/kg/hr on the day of intubation.
The threshold urine output most significantly associated with increased mortality as identified by an ROC
curve upon excluding these 10 patients from the analysis was less than 0.7 mL/kg/hr (AUC, 0.738; 95% CI,
4     www.ccejournal.org

0.68–0.795; p < 0.001), correlating with a sensitivity
of 79.1% and specificity of 53.8%. These findings are
highlighted in Figure 2.
A total of 180 patients (60%) fell below the identified threshold, termed low (< 0.7 mL/kg/hr) urine
output. When patients were recategorized according to
this designation, age (p < 0.001), creatinine (p < 0.001),
BMI (p < 0.001), history of CKD (p < 0.001), and
SOFA score at admission to the ICU (p < 0.001) were
significantly different between both high and low
urine output groups, in addition to P/F ratio on day
1 (172 ± 124 vs 144 ± 113; p = 0.015), plateau pressure
on day 3 (23 ± 7.0 vs 26 ± 7.0 cm H2O; p < 0.001), PEEP
on day 3 (9.6 ± 4.5 vs 11 ± 5.2 cm H2O; p < 0.001), and
net I/O on day 3 (2.1 ± 5.6 vs 3.4 ± 5.1 L; p = 0.042).
Baseline characteristics of low and high urine output
cohorts can be found in Table 2.
In assessing outcomes associated with urine output on
day of intubation above or below the specified threshold
of 0.7 mL/kg/hr, patients below the threshold experienced fewer VFD (6.77 ± 10 vs 13.4 ± 11; p < 0.001) and
increased need for emergent new RRT initiation (30% vs
13%; p = 0.003). There was no significant difference in
the use of vasopressor support or paralytics between the
two groups. Outcome results are highlighted in Table 3.

Figure 2. Patient inclusion and exclusion diagram. ARDS = acute
respiratory distress syndrome, EMR = electronic medical record.
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TABLE 2.

Baseline Characteristics and Risk Factors Associated With Mortality in Patients Categorized
by Low (< 0.7 cc/kg/hr) and High (> 0.7 cc/kg/hr) Urine Output
Baseline Characteristics

High, n = 118

Low, n = 180

p

Demographics
Age, mean (sd)

48.1 ± 15.1

60.4 ± 16.7

Male, n (%)

67 (57)

102 (57)

0.787

White, n (%)

57 (48)

104 (58)

0.332

Black, n (%)

44 (37)

65 (57)

0.716

26.6 ± 6.59

33.3 ± 10.4

Chronic obstructive pulmonary disease

67 (56)

102 (57)

0.787

Asthma

14 (12)

21 (12)

0.894

8 (7)

27 (15)

0.038

On home oxygen

10 (8)

26 (15)

0.144

Diabetes mellitus

37 (31)

68 (38)

0.337

Hypertension

60 (50)

126 (70)

0.003

Chronic kidney disease

16 (13)

59 (33)

< 0.001

Coronary artery disease

13 (11)

33 (19)

0.107

Congestive heart failure

10 (8)

38 (22)

0.005

Tobacco use

76 (63)

95 (54)

0.031

Prior venous thromboembolism

23 (19)

41 (24)

0.579

sCr on admit to ICU—mg/dL, mean (sd)

1.43 ± 1.39

2.00 ± 1.44

0.010

sCr on day 1 of MV—mg/dL, mean (sd)

1.44 ± 1.45

1.90 ± 1.44

< 0.001

Bicarbonate on day 1 of MV—mEq/L, mean (sd)

22.0 ± 5.54

21.0 ± 5.56

0.129

pH on day 1 of MV, mean (sd)

7.32 ± 0.121

Body mass index, mean (sd)

< 0.001

< 0.001

Comorbidities, n (%)

Obstructive sleep apnea

Severity of illness

7.0 ± 0.127

0.009

Acute respiratory distress syndrome severity, n (%)
  Moderate

68 (57)

72 (40)

  Severe

40 (42)

113 (63)

0.0015

   Net I/O on day 1 of MV—L

2.26 ± 4.98

2.84 ± 4.01

0.266

   Net I/O on day 3 of MV—L

2.07 ± 5.64

3.41 ± 5.14

0.042

   P/F on day 1 of MV

171 ± 124

145 ± 113

0.015

   P/F on day 3 of MV

180 ± 116

165 ± 92

0.263

   Sequential Organ Failure Assessment on admit to ICU

9.74 ± 3.00

11.5 ± 3.60

0.002

Pco2 on day 1 of MV, mean (sd)

< 0.001

I/O = intake and output, MV = mechanical ventilation, P/F = ratio of Pao2/Fio2, sCr = serum creatinine.
Significant p < 0.05 are bolded.

DISCUSSION
This was a retrospective, single-center study aiming
to investigate the relationship between development
of oliguric AKI, as measured by low urine output and
Critical Care Explorations

creatinine elevation, and mortality in patients hospitalized with all-cause ARDS. We hypothesized that oliguric AKI is an independent risk factor for all-cause
mortality in this population. This hypothesis was developed through careful examination of an ARDSNet
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TABLE 3.

Outcomes in Patients Categorized by Low (< 0.7 cc/kg/hr) and High (> 0.7 cc/kg/hr) Urine
Output
High, n = 118

Low, n = 180

Inpatient death, n (%)

27 (23)

109 (61)

< 0.001

Ventilator-free day—d, mean (sd)

13 ± 11

7 ± 10

< 0.001

ICU LOS—d, mean (sd)

20 ± 17

15 ± 13

0.030

Hospital LOS—d, mean (sd)

26 ± 21

19 ± 14

< 0.001

New renal replacement therapy initiation, n (%)

16 (13)

52 (30)

0.003

Vasopressor required, n (%)

34 (28)

72 (40)

0.073

Paralytics required, n (%)

25 (21)

50 (29)

0.263

Outcome

p

LOS = length of stay.
Significant p < 0.05 are bolded.

secondary analysis that identified a mortality benefit
with increased urine output at the time of ARDS development (7). We also attempted to investigate underlying risk factors for mortality in patients with AKI
prior to the onset of ARDS, as previously detailed in a
retrospective review (8).
Our results confirm the hypothesis that development of oliguric AKI on the day of intubation is independently associated with inpatient mortality, with a
urine output cutoff of less than 0.7 mL/kg/hr (termed
“low urine output”) serving as the single strongest factor associated with mortality, associated with roughly
80% of inpatient death in this cohort of patients with
ARDS that predominantly occurred secondary to bacterial pneumonia, sepsis, and postoperative complications. Shen et al (7) previously described the impact
of urine output on survival in the ARDS population,
using a novel calculation of urine output/fluid intake
ratio to yield a cutoff of 0.5, with urine output below
this significantly associated with mortality. However,
their study population included significantly fewer
Black patients (17.7% vs 35%), with no discussion regarding underlying history of CKD. The association
between baseline renal impairment and mortality,
predominantly in the ICU setting, is well documented
(3, 4, 6, 11, 12). Additionally, patients with a net
positive fluid balance may experience compounded
negative effects, including increased morbidity and
mortality (11–14). Therefore, to truly demonstrate
an association between urine output and mortality,
a heterogeneous sample of patients with and without
underlying CKD is pivotal, especially considering
6     www.ccejournal.org

such patients with baseline renal impairment are at
increased risk of AKI, which may lead to clinicians
overestimating fluid need. In our study, not only was
urine output on the day of intubation associated with
mortality at a RR of 0.388 (0.230–0.654), the cutoff
urine output of 0.7 mL/kg/hr predicted roughly 80%
of patient deaths in our cohort.
We further demonstrate several risk factors associated with mortality, including advanced age, elevated
BMI, history of CKD, degree of acidosis (indicated by
pH and bicarbonate levels) at the time of intubation,
and SOFA score at admission to the ICU. However, the
risk factor most significantly associated with mortality
in this population was reduction in day 1 urine output
(< 0.7 mL/kg/hr cutoff). In contrast, P/F was not a significant risk factor associated with mortality, primarily
due to the design of this cohort review. We selected
patients based on their P/F at the time of ARDS onset,
so all patients included were already predetermined to
have moderate-to-severe gas exchange abnormalities.
This association between oliguria on the day of intubation and mortality has significant clinical implications, providing a useful and easy-to-measure risk
factor for mortality on the first day of intubation in
patients with moderate-severe ARDS, with increased
practical application as compared with prior urine
output measures (7). Knowing the relationship between such a ubiquitous variable as urine output on
the day of intubation and mortality in ARDS can help
clinicians, even in resource-poor settings, to inform
discussions with patients and families about whether
mechanical ventilation should be pursued.
June 2022 • Volume 4 • Number 6
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Understanding how urine output is associated with
mortality and the factors associated with low urine
output, as demonstrated here, can aid providers in further risk stratifying patients with ARDS. Both ARDS and
mechanical ventilation itself are well-recognized risk factors for development of AKI (15), in addition to acidosis,
which leads to development and worsening of AKI (16).
But presence of renal injury prior to onset of ARDS is
a clinically significant mortality risk factor, a hypothesis
further supported by this study. The interplay of acidosis, progressive worsening of renal function, severity
of ARDS, and mortality further supports the idea that
ARDS is a multiple organ disease, and an inflammatory
pathway may explain mortality in these patients beyond
respiratory failure itself (1–3, 11, 12, 15). In particular,
our study recognized acidosis as a risk factor for mortality in ARDS, similar to prior investigations (7, 8).
Our study has several advantages. First, as stated
earlier, we include a large percentage of Black patients
with a high baseline prevalence of CKD. Additionally,
our large cohort of heterogeneous ARDS triggers
increases the applicability of the study. Last, the hand
abstracted nature of the data minimizes the risk of
clinically irrelevant or nonsensical values.
We do acknowledge several components that limit
the generalizability of our study. First, the retrospective nature of our review is, as all retrospective studies
are, prone to selection and detection bias, misclassification bias, and variability in both patient inclusion
and medical care. Additionally, patients were singlecenter, possibly lending performance bias. I/O data in
hospitalized patients is dependent on healthcare providers input into the EHR and prone to documentation
error. Last, data on the use of diuretics was not collected due to the significant variation in practice patterns regarding routine use of diuretics in patients with
AKI in the setting of ARDS. At our institution, use of
diuretics is not commonplace and so the utility of such
data was in question. The question regarding use of diuretic therapy in patients with AKI in the setting of
ARDS would best be answered in future investigations.

CONCLUSIONS
In this retrospective cohort review of patients admitted to the ICU with all-cause ARDS, oliguria on the
day of intubation was independently associated with
increased mortality. A cutoff of urine output less than
Critical Care Explorations

0.7 mL/kg/hr predicted 80% of inpatient deaths. Such
findings further advance the understanding of ARDS
as a systemic multiple organ disease, with extrapulmonary organ failure contributing to the burden of morbidity and mortality. Additionally, our findings can
be used to inform prognostication discussions with
patients and their families before intubation, empowering those we care for to make goals of care decisions
that are congruent with their values and anticipated
outcomes.
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